ProCE Banner Activity

Key Decisions in HIV Care: Considering Novel Therapies for HIV

Podcast Episodes
In this on-demand recording of a live webinar, expert faculty review key considerations for the use of current and future HIV novel therapies, including as prevention, initial treatment, switch strategies, and in heavily treatment–experienced patients with HIV.

Released: May 02, 2022

Expiration: May 01, 2023

No longer available for credit.

Share

Faculty

William R. Short

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine and Obstetrics and Gynecology
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine and Obstetrics and Gynecology
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, MD, MPH, AAHIVS, has disclosed that he has received fees for non-CME/CE services from Janssen and consulting fees from ViiV.